RESVERAC

Pharmaceutical and veterinary preparations for treatment of cellular damage due to oxidating agents, DNA damage due to estrogen initiated cancers, general decay of vascular, skeletal and neuro-muscular system, and vitamin D3 deficiency; medicines for treatment of cellular damage due to oxidating agents, DNA damage due to estrogen initiated cancers, general decay of vascular, skeletal and neuro-muscular system, and vitamin D3 deficiency for human and animal use; dietetic substances, namely, antioxidants, chelating agents and D3 vitamins adapted for medical or veterinary use; dietary supplements for humans and animals; dietary food supplements * none of the aforementioned being for use in relation to ocular, periocular or sight fields *